MTOR and Hyperglycemia: Because hyperglycemia occurs along with hyperinsulinemia in obese type 2 diabetic patients, combined hyperinsulinemic and hyperglycemia would be expected to activate the mTOR pathway in obese and type 2 diabetic patients.